 |
市场调查报告书
商品编码
1900647
医学影像诊断剂市场规模、份额及成长分析（按类型、模式、技术、应用和地区划分）－2026-2033年产业预测Medical Imaging Reagents Market Size, Share, and Growth Analysis, By Class (Contrast reagents, Optical reagents), By Modality (X-ray, CT Scan), By Technology, By Application, By Region - Industry Forecast 2026-2033 |
||||||
预计到 2024 年，医疗影像诊断剂市场规模将达到 182.5 亿美元，到 2025 年将达到 192 亿美元，到 2033 年将达到 288 亿美元，预测期（2026-2033 年）的复合年增长率为 5.2%。
全球医学影像诊断剂市场是医疗保健产业的重要组成部分，为诊断和检查提供关键工具。这些试剂能够增强磁振造影（MRI）、电脑断层扫描（CT）、超音波和核子医学等影像技术中特定组织和器官的对比和可见度。推动市场发展的关键因素包括慢性病发病率的上升、人口老化以及对早期精准疾病诊断日益增长的需求。医学影像诊断剂显着提高了诊断准确性和治疗方案的製定，从而有助于改善患者的治疗效果。分子成像技术正蓬勃发展，这需要能够靶向特定分子以更好地表征疾病的先进试剂。目前，研究人员正在不断开发安全且高效的试剂，而混合成像系统也推动了适用于多种成像模式的多功能解决方案的需求。
医学影像诊断剂市场驱动因素
癌症、心血管疾病和神经系统疾病等慢性疾病发生率的不断上升，显着推动了对医学成像技术的需求。在此背景下，医学诊断剂至关重要，因为它们能够提高诊断成像过程的准确性和有效性。这些改进转化为更好的患者预后，促使医疗机构更广泛地采用这些试剂。因此，对先进成像解决方案的需求持续成长，推动了医学影像诊断剂市场的扩张。这一趋势反映了透过提升诊断能力来改善医疗服务的更广泛努力。
医疗影像诊断剂市场的限制
由于PET和MRI等先进影像技术高成本，医学影像诊断剂市场面临巨大的限制。这些试剂连同相关设备和医疗服务，给医疗机构和患者都带来了沉重的经济负担。这种经济挑战可能会阻碍市场成长，尤其是在低收入地区和此类技术普及率较低的地区。这些成像诊断剂的高昂价格可能会阻碍其广泛应用，并导致医疗品质的差异，从而限制不同族群医学影像技术的发展。
医疗影像诊断剂市场趋势
受分子造影剂（尤其是用于正子断层扫描 (PET) 和单光子发射电脑断层扫描 (SPECT) 的放射性药物）需求不断增长的驱动，医学成像诊断剂市场正经历着显着的变革。这些先进的试剂增强了我们在分子和细胞层面上可视化和量化生物过程的能力，从而显着改善了疾病的早期检测、治疗方案製定和后续观察。放射性药物研发的持续进展，尤其是在开发更具标靶性和特异性的药物方面，进一步加速了这一趋势。随着医疗保健越来越重视精准医疗，对创新诊断剂的需求预计将会成长，从而塑造未来医学诊断的格局。
目录
介绍
- 调查目标
- 调查范围
- 定义
调查方法
- 资讯收集
- 二手资料和一手资料方法
- 市场规模预测
- 市场假设与限制
执行摘要
- 全球市场展望
- 供需趋势分析
- 细分市场机会分析
市场动态与展望
- 市场规模
- 市场动态
- 驱动因素和机会
- 限制与挑战
- 波特分析
关键市场考察
- 关键成功因素
- 竞争程度
- 关键投资机会
- 市场生态系统
- 市场吸引力指数（2025）
- PESTEL 分析
- 总体经济指标
- 价值链分析
- 定价分析
- 技术分析
全球医学影像诊断剂市场规模（按类型和复合年增长率划分）（2026-2033 年）
- 造影
- 光学试剂
- 核医学试剂
全球医学影像诊断剂市场规模（依模式及复合年增长率划分）（2026-2033 年）
- X射线
- 电脑断层扫描
- 超音波
- 磁振造影
全球医学影像诊断剂市场规模（依技术及复合年增长率划分）（2026-2033 年）
- 奈米颗粒
- 萤光染料和探针
- 放射性药物
- 萤光蛋白
- 量子点
全球医学影像诊断剂市场规模（按应用及复合年增长率划分）（2026-2033 年）
- 诊断
- 药物发现与开发
- 教育研究
全球医学影像诊断剂市场规模及复合年增长率（2026-2033）
- 北美洲
- 美国
- 加拿大
- 欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
- 亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
- 拉丁美洲
- 巴西
- 其他拉丁美洲地区
- 中东和非洲
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区
竞争资讯
- 前五大公司对比
- 主要企业的市场定位（2025 年）
- 主要市场参与者所采取的策略
- 近期市场趋势
- 公司市占率分析（2025 年）
- 主要企业公司简介
- 公司详情
- 产品系列分析
- 依业务板块进行公司股票分析
- 2023-2025年营收年比比较
主要企业简介
- GE Healthcare（USA）
- Siemens Healthineers（Germany）
- Bracco Imaging SpA（Italy）
- Bayer AG（Germany）
- Guerbet Group（France）
- Lantheus Holdings Inc.（USA）
- Jubilant Radiopharma（India）
- Cardinal Health Inc.（USA）
- Nordion（Canada）Inc.（Canada）
- Curium Pharma（France）
- Advanced Accelerator Applications（AAA）-A Novartis Company（Switzerland）
- Eli Lilly and Company（USA）
- Thermo Fisher Scientific Inc.（USA）
- PerkinElmer Inc.（USA）
- Agfa-Gevaert Group（Belgium）
- Merck KGaA（Germany）
- Triad Isotopes Inc.（USA）
- Nihon Medi-Physics Co. Ltd.（Japan）
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd.（China）
- EczacIbasI-Monrol Nuclear Products（Turkey）
结论与建议
Medical Imaging Reagents Market size was valued at USD 18.25 Billion in 2024 and is poised to grow from USD 19.2 Billion in 2025 to USD 28.8 Billion by 2033, growing at a CAGR of 5.2% during the forecast period (2026-2033).
The global medical imaging reagents market is an essential component of the healthcare sector, providing vital tools for diagnostics and research. These reagents enhance the contrast and visibility of specific tissues or organs in imaging techniques such as MRI, CT, ultrasound, and nuclear medicine. Key market drivers include the rising prevalence of chronic diseases, an increasing aging population, and the demand for early and accurate disease diagnosis. Medical imaging reagents significantly improve diagnostic accuracy and treatment planning, thereby facilitating better patient outcomes. There is a notable trend towards molecular imaging techniques, which require advanced reagents targeting specific molecules, enhancing disease characterization. Ongoing research aims to develop safer, more efficient reagents, while hybrid imaging systems are catalyzing demand for versatile solutions applicable across multiple imaging modalities.
Top-down and bottom-up approaches were used to estimate and validate the size of the Medical Imaging Reagents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Medical Imaging Reagents Market Segments Analysis
Global Medical Imaging Reagents Market is segmented by Class, Modality, Technology, Application and region. Based on Class, the market is segmented into Contrast reagents, Optical reagents and Nuclear reagents. Based on Modality, the market is segmented into X-ray, CT Scan, Ultrasound and MRI Scan. Based on Technology, the market is segmented into Nanoparticles, Fluorescent dyes & probes, Radiopharmaceuticals, Fluorescent proteins and Quantum dots. Based on Application, the market is segmented into Diagnostics, Drug discovery & development and Educational Research. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Medical Imaging Reagents Market
The rising incidence of chronic illnesses such as cancer, cardiovascular disorders, and neurological conditions has significantly heightened the demand for medical imaging techniques. Within this context, medical imaging reagents are essential, as they enhance both the precision and effectiveness of diagnostic imaging processes. This enhancement leads to improved patient outcomes and encourages healthcare providers to adopt these reagents more widely. As a result, the need for advanced imaging solutions continues to grow, driving the expansion of the medical imaging reagents market. This trend reflects a broader commitment to improving healthcare delivery through enhanced diagnostic capabilities.
Restraints in the Medical Imaging Reagents Market
The medical imaging reagents market faces a significant constraint due to the high costs associated with advanced imaging techniques such as PET and MRI. These reagents, along with the equipment and related healthcare services, present a considerable financial burden for both healthcare facilities and patients. This economic challenge can hinder market growth, particularly in regions with lower income levels, where access to such technologies is limited. The expensive nature of these imaging reagents impedes widespread adoption and may lead to disparities in healthcare quality, thereby potentially restricting advancements in medical imaging practices across various demographics.
Market Trends of the Medical Imaging Reagents Market
The Medical Imaging Reagents market is witnessing a notable shift driven by the growing demand for molecular imaging agents, particularly positron emission tomography (PET) and single-photon emission computed tomography (SPECT) radiopharmaceuticals. These advanced reagents enhance the ability to visualize and quantify biological processes at the molecular and cellular levels, significantly improving early disease detection, treatment planning, and monitoring. Continuous advancements in radiopharmaceutical development, focusing on the creation of more targeted and specific agents, are further fueling this trend. As healthcare increasingly prioritizes precision medicine, the need for innovative imaging reagents is expected to rise, thereby shaping the future landscape of medical diagnostics.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2025
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
- Technology Analysis
Global Medical Imaging Reagents Market Size by Class & CAGR (2026-2033)
- Market Overview
- Contrast reagents
- Optical reagents
- Nuclear reagents
Global Medical Imaging Reagents Market Size by Modality & CAGR (2026-2033)
- Market Overview
- X-ray
- CT Scan
- Ultrasound
- MRI Scan
Global Medical Imaging Reagents Market Size by Technology & CAGR (2026-2033)
- Market Overview
- Nanoparticles
- Fluorescent dyes & probes
- Radiopharmaceuticals
- Fluorescent proteins
- Quantum dots
Global Medical Imaging Reagents Market Size by Application & CAGR (2026-2033)
- Market Overview
- Diagnostics
- Drug discovery & development
- Educational Research
Global Medical Imaging Reagents Market Size & CAGR (2026-2033)
- North America (Class, Modality, Technology, Application)
- US
- Canada
- Europe (Class, Modality, Technology, Application)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Class, Modality, Technology, Application)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Class, Modality, Technology, Application)
- Brazil
- Rest of Latin America
- Middle East & Africa (Class, Modality, Technology, Application)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2025
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2025
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2023-2025)
Key Company Profiles
- GE Healthcare (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Siemens Healthineers (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bracco Imaging S.p.A. (Italy)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Bayer AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Guerbet Group (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lantheus Holdings Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Jubilant Radiopharma (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Cardinal Health Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nordion (Canada) Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Curium Pharma (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Advanced Accelerator Applications (AAA) - A Novartis Company (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Eli Lilly and Company (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Thermo Fisher Scientific Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- PerkinElmer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Agfa-Gevaert Group (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Triad Isotopes Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Nihon Medi-Physics Co. Ltd. (Japan)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Shenzhen Mindray Bio-Medical Electronics Co. Ltd. (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- EczacIbasI-Monrol Nuclear Products (Turkey)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations
微生物试剂市场－全球产业规模、份额、趋势、机会和预测，按类型、试剂类型、产品类型、最终用户产业、地区和竞争格局划分，2020-2030年预测青蒿酸市场－全球产业规模、份额、趋势、机会和预测，按类型（全合成、半合成）、应用（抗疟注射、抗疟锭）、地区和竞争格局划分，2020-2030年预测
感染疾病诊断剂市场规模、份额和趋势分析报告：按产品、治疗领域、技术、最终用途、地区和细分市场预测（2025-2033 年）美国青蒿素酸市场规模、份额和趋势分析报告：按产品和细分市场预测（2025-2033 年）
三氯化硼市场依等级、製造方法、产品形态、最终用户及通路划分－2025年至2032年全球预测生化试剂市场：2025-2032年全球预测（依产品类型、应用、最终用户、原料及等级划分）生物成像试剂市场按产品类型、成像方式、最终用户和应用划分－2025-2032年全球预测生物成像试剂市场按产品类型、技术、应用和最终用户划分－2025-2032年全球预测
全球生物与医学成像试剂市场
对乙酰胺酚市场：按产品形式、按给药途径、按用途、按产品类型、按销售类型、按年龄组、按性别、按强度、按分销渠道、按最终用户、按地区